Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
13.56
-0.18 (-1.31%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Inhibrx Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Inhibrx.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Inhibrx is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 23, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $27 | Buy | Reiterates | $27 | +99.12% | Nov 20, 2023 |
JMP Securities | JMP Securities | Buy Maintains $35 → $27 | Buy | Maintains | $35 → $27 | +99.12% | Aug 23, 2023 |
JMP Securities | JMP Securities | Buy Reiterates $35 | Buy | Reiterates | $35 | +158.11% | May 10, 2023 |
JMP Securities | JMP Securities | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +158.11% | Mar 8, 2023 |
Financial Forecast
Revenue This Year
n/a
from 1.63M
Revenue Next Year
2.04M
EPS This Year
-5.98
EPS Next Year
-6.29
from -5.98
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | 2.1M | 128.1M |
Avg | n/a | 2.0M | 124.4M |
Low | n/a | 2.0M | 119.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | 6,192.9% |
Avg | - | - | 6,013.0% |
Low | - | - | 5,773.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -6.14 | -6.48 | -5.29 |
Avg | -5.98 | -6.29 | -5.14 |
Low | -5.76 | -6.05 | -4.94 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.